Cooper Companies Inc (NYSE:COO) Director Stanley Md Zinberg sold 5,000 shares of Cooper Companies stock in a transaction that occurred on Thursday, January 4th. The shares were sold at an average price of $224.66, for a total transaction of $1,123,300.00. Following the sale, the director now directly owns 6,090 shares of the company’s stock, valued at approximately $1,368,179.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Cooper Companies Inc (NYSE COO) traded down $3.19 during midday trading on Thursday, reaching $223.55. 561,320 shares of the company’s stock traded hands, compared to its average volume of 506,333. The company has a quick ratio of 1.26, a current ratio of 2.41 and a debt-to-equity ratio of 0.36. Cooper Companies Inc has a fifty-two week low of $175.30 and a fifty-two week high of $256.39. The stock has a market capitalization of $11,100.00, a price-to-earnings ratio of 29.73, a P/E/G ratio of 1.78 and a beta of 0.54.

Cooper Companies (NYSE:COO) last released its quarterly earnings results on Thursday, December 7th. The medical device company reported $2.65 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.64 by $0.01. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. The business had revenue of $561.50 million for the quarter, compared to analyst estimates of $558.86 million. During the same period in the previous year, the company earned $2.28 earnings per share. The business’s revenue for the quarter was up 8.3% on a year-over-year basis. analysts forecast that Cooper Companies Inc will post 11.51 EPS for the current year.

COO has been the subject of several research analyst reports. Zacks Investment Research downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Monday, September 18th. Raymond James Financial reissued a “buy” rating and issued a $265.00 price objective on shares of Cooper Companies in a research note on Monday, December 4th. Robert W. Baird set a $273.00 price objective on shares of Cooper Companies and gave the stock a “buy” rating in a research note on Monday, October 16th. BMO Capital Markets reissued a “buy” rating and issued a $272.00 price objective on shares of Cooper Companies in a research note on Friday, October 13th. Finally, KeyCorp reissued a “hold” rating on shares of Cooper Companies in a research note on Friday, October 20th. Six equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $259.70.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Parametric Portfolio Associates LLC grew its holdings in shares of Cooper Companies by 17.5% during the third quarter. Parametric Portfolio Associates LLC now owns 71,701 shares of the medical device company’s stock valued at $17,001,000 after buying an additional 10,677 shares during the last quarter. AXA grew its holdings in shares of Cooper Companies by 3.0% during the third quarter. AXA now owns 193,969 shares of the medical device company’s stock valued at $45,992,000 after buying an additional 5,725 shares during the last quarter. GSA Capital Partners LLP grew its holdings in shares of Cooper Companies by 354.8% during the third quarter. GSA Capital Partners LLP now owns 6,449 shares of the medical device company’s stock valued at $1,529,000 after buying an additional 5,031 shares during the last quarter. California Public Employees Retirement System grew its holdings in shares of Cooper Companies by 11.4% during the third quarter. California Public Employees Retirement System now owns 120,582 shares of the medical device company’s stock valued at $28,591,000 after buying an additional 12,382 shares during the last quarter. Finally, Janney Montgomery Scott LLC grew its holdings in shares of Cooper Companies by 3.5% during the third quarter. Janney Montgomery Scott LLC now owns 10,817 shares of the medical device company’s stock valued at $2,565,000 after buying an additional 363 shares during the last quarter. 96.73% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Stanley Md Zinberg Sells 5,000 Shares of Cooper Companies Inc (COO) Stock” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2018/01/04/stanley-md-zinberg-sells-5000-shares-of-cooper-companies-inc-coo-stock.html.

Cooper Companies Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Insider Buying and Selling by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.